PREFORMULATION STUDY OF ETOPOSIDE - IDENTIFICATION OF PHYSICOCHEMICAL CHARACTERISTICS RESPONSIBLE FOR THE LOW AND ERRATIC ORAL BIOAVAILABILITY OF ETOPOSIDE

被引：79

作者：

SHAH, JC

CHEN, JR

CHOW, D

机构：

[1] UNIV HOUSTON, DEPT PHARMACEUT, 1441 MOURSUND ST, HOUSTON, TX 77030 USA

[2] BOOTS USA INC, SHREVEPORT, LA USA

来源：

关键词：

D O I：

10.1023/A:1015935532725

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：408 / 412

页数：5

共 16 条

[1] CARSTENSEN JT, 1974, DISSOLUTION TECHNOLO, P1
[2] STABILITY-INDICATING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF ETOPOSIDE AT VARIOUS PH CONDITIONS USING A REVERSED-PHASE OCTYL COLUMN
CHOW, D
SHAH, J
CHEN, JR
[J]. JOURNAL OF CHROMATOGRAPHY, 1987, 396 : 217 - 223
[3] THE CLINICAL-PHARMACOLOGY OF ETOPOSIDE AND TENIPOSIDE
CLARK, PI
SLEVIN, ML
[J]. CLINICAL PHARMACOKINETICS, 1987, 12 (04) : 223 - 252
[4] DORR R, 1980, ETOPOSIDE VP 16 CANC, P418
[5] FALKSON G, 1975, CANCER, V35, P1141, DOI 10.1002/1097-0142(197504)35:4<1141::AID-CNCR2820350418>3.0.CO
[6] 2-3
[7] GREENE D, 1979, MODERN PHARM, P214
[8] ISSELL BF, 1984, ETOPOSIDE VP 16, P4
[9] KAPLAN S A, 1972, Drug Metabolism Reviews, V1, P15, DOI 10.3109/03602537208993907
[10] LAU ME, 1979, CANCER TREAT REP, V63, P485